<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02823457</url>
  </required_header>
  <id_info>
    <org_study_id>53635</org_study_id>
    <nct_id>NCT02823457</nct_id>
  </id_info>
  <brief_title>VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C</brief_title>
  <acronym>VBMI SUD/HCV</acronym>
  <official_title>Evaluating Values-based Motivational Interviewing to Increase Treatment Completion With Fixed Dose Combination MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders and Treatment-naïve Genotype 1 Chronic Hepatitis C</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>G.V. (Sonny) Montgomery VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>G.V. (Sonny) Montgomery VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study implement a values-based motivational interviewing (VBMI) intervention to promote&#xD;
      treatment completion with fixed dose combination (FDC) MK-5172/MK-8742 x 12 weeks among 30&#xD;
      Veterans with substance use disorder (SUD) and treatment naïve genotype 1 chronic hepatitis C&#xD;
      virus (HCV) infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators will conduct a prospective study of 30 Veterans with treatment-naive&#xD;
      genotype 1 chronic hepatitis C infection admitted to the Substance Abuse Residential&#xD;
      Rehabilitation Treatment Program (SARRTP) at the G.V. (Sonny) Montgomery VA Medical Center.&#xD;
      Enrolled veterans will be treated MK-5172/MI-8742 while receiving a 12 week values based&#xD;
      motivational intervention to promote completion of HCV treatment. MK-5172/MK-8742 will be&#xD;
      prescribed in accordance with the package insert.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 5, 2017</start_date>
  <completion_date type="Actual">January 30, 2020</completion_date>
  <primary_completion_date type="Actual">January 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>open label</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Completion</measure>
    <time_frame>12 weeks after initiation treatment</time_frame>
    <description>Number of participants who completed treatment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sustained Virologic Response</measure>
    <time_frame>an average of 3 months after treatment completion</time_frame>
    <description>Number of participants who achieved SVR</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Patient Adherence, Chronic Hepatitis C, Alcohol-related Disorders</condition>
  <arm_group>
    <arm_group_label>VBMI intervention group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All patients will receive a 12 week VBMI intervention to promote treatment completion</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>VBMI</intervention_name>
    <description>12 week values based motivational interviewing intervention with a licensed psychologist</description>
    <arm_group_label>VBMI intervention group</arm_group_label>
    <other_name>Values Based Motivational Interviewing</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Identified as having treatment-naïve genotype 1 chronic HCV infection; Veterans who&#xD;
             are genotype 1a must have baseline NS5a resistance testing&#xD;
&#xD;
          2. Current resident of the SARRTP program&#xD;
&#xD;
          3. Willing to initiate treatment with FDC MK-5172/MK-8742 during SARRTP and up to 30 days&#xD;
             post-discharge.&#xD;
&#xD;
          4. Willing to attend coordinated HCV treatment clinic visits and substance abuse&#xD;
             aftercare visits every 2 weeks upon SARRTP discharge&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Contraindications for therapy with FDC MK-5172/MK-8742&#xD;
&#xD;
          2. Unable to provide written informed consent&#xD;
&#xD;
          3. Hepatocellular carcinoma or other medical condition precluding HCV treatment&#xD;
&#xD;
          4. Acute HCV infection&#xD;
&#xD;
          5. Prior treatment for chronic HCV&#xD;
&#xD;
          6. History of decompensated cirrhosis&#xD;
&#xD;
          7. Platelet count &lt; 75 K/cmm and/or albumin &lt; 3 grams/dL&#xD;
&#xD;
          8. Females and male sex partners of females who are pregnant, nursing and/or unwilling to&#xD;
             use contraception&#xD;
&#xD;
          9. Patients infected with genotype 1a who have not undergone baseline NS5a resistance&#xD;
             testing&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mary Burton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>G.V. (Sonny) Montgomery VAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>GV Sonny Montgomery VAMC</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>July 1, 2016</study_first_submitted>
  <study_first_submitted_qc>July 1, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2016</study_first_posted>
  <results_first_submitted>December 11, 2020</results_first_submitted>
  <results_first_submitted_qc>January 7, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">January 12, 2021</results_first_posted>
  <last_update_submitted>January 7, 2021</last_update_submitted>
  <last_update_submitted_qc>January 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>G.V. (Sonny) Montgomery VA Medical Center</investigator_affiliation>
    <investigator_full_name>Mary Jane Burton</investigator_full_name>
    <investigator_title>Staff Physician</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Hepatitis, Chronic</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Alcohol-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>June 10, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/57/NCT02823457/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>VBMI Intervention Group</title>
          <description>All patients will receive a 12 week VBMI intervention to promote treatment completion&#xD;
VBMI: 12 week values based motivational interviewing intervention with a licensed psychologist</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="20"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>VBMI Intervention Group</title>
          <description>All patients will receive a 12 week VBMI intervention to promote treatment completion&#xD;
VBMI: 12 week values based motivational interviewing intervention with a licensed psychologist</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="20"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="65.0" spread="6.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Treatment Completion</title>
        <description>Number of participants who completed treatment</description>
        <time_frame>12 weeks after initiation treatment</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VBMI Intervention Group</title>
            <description>All patients will receive a 12 week VBMI intervention to promote treatment completion&#xD;
VBMI: 12 week values based motivational interviewing intervention with a licensed psychologist</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Completion</title>
          <description>Number of participants who completed treatment</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sustained Virologic Response</title>
        <description>Number of participants who achieved SVR</description>
        <time_frame>an average of 3 months after treatment completion</time_frame>
        <group_list>
          <group group_id="O1">
            <title>VBMI Intervention Group</title>
            <description>All patients will receive a 12 week VBMI intervention to promote treatment completion&#xD;
VBMI: 12 week values based motivational interviewing intervention with a licensed psychologist</description>
          </group>
        </group_list>
        <measure>
          <title>Sustained Virologic Response</title>
          <description>Number of participants who achieved SVR</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="20"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Six months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>VBMI Intervention Group</title>
          <description>All patients will receive a 12 week VBMI intervention to promote treatment completion&#xD;
VBMI: 12 week values based motivational interviewing intervention with a licensed psychologist</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="20"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mary Jane Burton</name_or_title>
      <organization>GV Sonny Montgomery VAMC</organization>
      <phone>6013624471</phone>
      <email>mary.burton2@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

